Genta - der letzte Thread
Wenn die Q1 richtig mies ausfallen kommen wir vlt. an noch günstigere Kurse, wollen wir aber nicht hoffen.
Mal gucken was die Amis heute machen...
Eins muss man Genta aber immer lassen, auch wenn die Geldbeschaffungsmethoden sicher ein wenig "gewöhnungsbedürftig" sind, irgendwas scheint sie dazu zu bewegen nicht aufzugeben.
Leverage
Moderation
Zeitpunkt: 13.05.10 08:25
Aktion: Löschung des Beitrages
Kommentar: Off-Topic - bitte nur zur im thread besprochenen Aktie posten
Zeitpunkt: 13.05.10 08:25
Aktion: Löschung des Beitrages
Kommentar: Off-Topic - bitte nur zur im thread besprochenen Aktie posten
Currently Genta's stock price has bottomed at around .06 (which is a far cry from its 52 week high of $1.26.) According to Market Financial, Genta is "Poised For A Rebound Year Based On Latest Company Developments." Genta's stock will be volatile this week and could easily triple on good news from the Company. Genta is current, and always has been, with all SEC filings.
Genta-Aktie wird in dieser Woche volatil sein und könnte leicht verdreifachen auf gute Nachrichten aus dem Unternehmen.
Nicht alles scheint so schlecht zu sein!!
Keine Kauf Empfehlung!! Wer nicht fähig ist, selber eine Meinung zu bilden und eine Entscheidung zu treffen, darf nicht zur Börse.
Als Investierter und stiller Mitleser möchte ich allen mal für die Infos hier im Gentaforum danken.
Lg
Madlog
Rechtschreibfehler könnt Ihr behalten. :-)
May 13, 2010
BERKELEY HEIGHTS, NJ – May 13, 2010 – Genta Incorporated (OTCBB: GNTA.OB) today announced financial results for the quarter ended March 31, 2010. Corporate highlights for the quarter included:
Closed financing of convertible debt and warrants
Initiated confirmatory Phase 2b trial of tesetaxel in 2nd-line gastric cancer
Initiated new clinical trial of tesetaxel using weekly dosing schedule
Survival followup continued in AGENDA Phase 3 trial of Genasense® in advanced melanoma; completion expected Q1 2011
Multiple abstracts accepted for ASCO presentations June 2010
Financial Results
The net loss for the quarter ended March 31, 2010 was $(166.6) million, or $(0.76) per share, compared with a net loss of $(11.1) million, or $(0.64) per share, for the first quarter of 2009. At March 31, 2010, Genta had cash and cash equivalents totaling $19.6 million compared with $1.2 million at December 31, 2009. Net cash used in operating activities through March 31, 2010 was $2.3 million.
As previously reported, in March 2010, the Company closed on a financing, whereby it issued $25 million of units consisting of $20 million of various senior unsecured convertible notes, $5 million of senior secured convertible notes and warrants to purchase additional senior unsecured convertible notes of $10.0 million. The Company had direct access to $20 million of the proceeds, and the remaining $5 million of the proceeds were placed in a blocked account as collateral security for the $5 million of secured notes. Also in March 2010, three investors who had participated in our April 2009 financing, exercised their rights to acquire convertible notes of $0.9 million. There was an insufficient number of authorized shares of common stock in order to permit conversion of all of the notes and warrants associated with these transactions. Accordingly, the conversion obligation for the notes and warrants were classified as liabilities and measured at fair value on the balance sheet, resulting in a total non-cash expense of $153.8 million for the first quarter of 2010. The conversion feature liabilities and the warrant liabilities will be accounted for using mark-to-market accounting at each future reporting date until all the criteria for permanent equity have been met. The Company has filed a proxy with the Securities and Exchange Commission that seeks authorization from Genta’s stockholders to authorize the Board of Directors to effect a reverse stock split that would among other effects provide sufficient equity to meet the permanent equity criteria.
Conference Call and Webcast
Genta management will host a conference call and live audio webcast to discuss financial results and recent corporate activities at 8:00 am ET. Participants can access the live call by dialing (877) 634-8606 (U.S. and Canada) or (973) 200-3973 (International). The access code for the live call is Genta Incorporated. The call will also be webcast live at http//:www.genta.com/investorrelation/events.html. For investors unable to participate in the live call, a replay will be available approximately two hours after the completion of the call, and will be archived for 30 days. Access numbers for this replay are: (800) 642-1687 (U.S. and Canada) and (706) 645-9291 (International); conference ID number is: 73085069.
Wichtig ist für mich erst mal dass es nicht so schlimm gekommen ist wie manche vermutet haben. Ob nun so schnell ein verdreifacher raus schaut weiss ich nicht, aber meiner Meinung nach könnte nach dieser Ausgangslage hier schon mal wieder einiges zu holen sein.
Wie allerdings auch schon erwähnt, kommt es jetzt auch auf die Ami's an was die heute draus machen werden. Im Moment ist die Stimmung an der Börse aber allgemein gut, von daher könnte es also durchaus schon möglich sein dass wir hier positiv überrascht werden könnten.
Leverage
Ich persönlich kann mit den Zahlen leben.(Nur vom Kurs noch nicht.)Aber das wird noch.
Schönen Vatertag noch.
Gruss